Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative laser systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is renowned for its proprietary MicroPulse® technology, a tissue-sparing laser delivery therapy used for treating a variety of retinal diseases and glaucoma. Iridex is dedicated to providing ophthalmologists with advanced solutions that improve patient outcomes and enhance the quality of care for sight-threatening eye conditions. Their products are used by leading eye care professionals globally.
Serves as the central hub for Iridex's global operations, including research and development, manufacturing, marketing, sales, and corporate administration.
The facility likely houses advanced R&D labs for laser technology development and manufacturing spaces compliant with medical device standards. Its location in Silicon Valley provides access to a rich talent pool and technology ecosystem.
As a medical technology company, the culture likely emphasizes innovation, precision, collaboration, and a strong commitment to improving patient care. Employees often work in cross-functional teams focused on developing and delivering high-quality ophthalmic solutions.
The Mountain View headquarters is strategically important for Iridex, placing it near other leading technology and medical device companies, research institutions, and sources of venture capital, fostering innovation and partnerships.
Iridex Corporation supports its global operations primarily from its headquarters in Mountain View, California. The company's products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and an extensive network of independent distributors, reaching over 100 countries. This model allows Iridex to provide sales, service, and clinical support for its ophthalmic laser systems and MicroPulse technology to eye care professionals worldwide.
1212 Terra Bella Ave
Mountain View
CA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Micropulse' leadership includes:
Micropulse has been backed by several prominent investors over the years, including:
In the past 12 months, Iridex Corporation has strengthened its executive team with a key appointment in Operations & Engineering to support its strategic growth initiatives. No major publicly announced executive exits have been prominently featured during this period.
Discover the tools Micropulse uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Iridex Corporation commonly uses an email format combining the first initial and full last name. For example, an employee named Jane Smith would likely have an email address like jsmith@iridex.com. Other formats might exist within the organization, but this is a frequently observed pattern.
flast@iridex.com (e.g., jsmith@iridex.com)
Format
dbruce@iridex.com
Example
85%
Success rate
Iridex Corporation Investor Relations / GlobeNewswire • May 9, 2024
Iridex Corporation reported financial results for the first quarter ended March 30, 2024, detailing revenue of $12.6 million, gross margin performance, and progress on its strategic initiatives. The company emphasized its focus on expanding the adoption of its MicroPulse Transscleral Laser Therapy for glaucoma and retina product lines....more
Iridex Corporation Investor Relations / GlobeNewswire • March 20, 2024
Iridex Corporation announced the appointment of Priyatham Salguti to the newly created role of Senior Vice President, Operations & Engineering. Mr. Salguti will lead Iridex’s operations, manufacturing, supply chain, and engineering development efforts, bringing over 20 years of experience in the medical device industry....more
Iridex Corporation Investor Relations / GlobeNewswire • April 1, 2024
Iridex announced its participation and product showcase at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting from April 5-8, 2024, in Boston, MA. The company highlighted its comprehensive suite of innovative glaucoma and retina treatment solutions, including its leading MicroPulse® technology and disposables....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Micropulse, are just a search away.